[1]
“INITIAL EVALUATION OF THE EFFICACY OF LOW-DOSE THALIDOMIDE COMBINED WITH CORTICOSTEROIDS IN PATIENTS WITH MYELOFIBROSIS AT THE NATIONAL INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION”, YHCĐ, vol. 67, no. 5, May 2026, doi: 10.52163/yhc.v67i5.5153.